Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics.
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ metabolism
Drug Resistance, Bacterial
/ drug effects
Gram-Positive Bacteria
/ drug effects
Gram-Positive Bacterial Infections
/ drug therapy
Humans
Lipoglycopeptides
/ pharmacology
Microbial Sensitivity Tests
/ methods
Molecular Docking Simulation
/ methods
Teicoplanin
/ pharmacology
Vancomycin
/ pharmacology
Enterococcus faecium
MD simulation
Staphylococcus aureus
antibiotic resistance
benzimidazole
docking
ligands
lipoglycopeptide antibiotic
teicoplanin VanZ
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Dec 2021
22 Dec 2021
Historique:
received:
22
11
2021
revised:
17
12
2021
accepted:
19
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
1
2
2022
Statut:
epublish
Résumé
Teicoplanin is a natural lipoglycopeptide antibiotic with a similar activity spectrum as vancomycin; however, it has with the added benefit to the patient of low cytotoxicity. Both teicoplanin and vancomycin antibiotics are actively used in medical practice in the prophylaxis and treatment of severe life-threatening infections caused by gram-positive bacteria, including methicillin-resistant
Identifiants
pubmed: 35008521
pii: ijms23010097
doi: 10.3390/ijms23010097
pmc: PMC8744867
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
Lipoglycopeptides
0
Teicoplanin
61036-62-2
Vancomycin
6Q205EH1VU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Health of the Czech Republic
ID : NU20-03-00309
Organisme : BIOCEV
ID : CZ.1.05/1.1.00/02.0109
Organisme : Institute of Biotechnology RVO
ID : 86652036
Organisme : Czech Science Foundation
ID : 20-09811Y
Organisme : Czech Academy of Sciences
ID : LQ200202002
Organisme : Czech Science Foundation
ID : 19-08176S
Références
J Med Chem. 2012 Mar 8;55(5):2163-72
pubmed: 22296601
Nanomaterials (Basel). 2020 Apr 17;10(4):
pubmed: 32316666
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Biomacromolecules. 2018 Mar 12;19(3):1006-1015
pubmed: 29443506
Nanomaterials (Basel). 2019 Oct 16;9(10):
pubmed: 31623115
J Biomol NMR. 1996 Dec;8(4):477-86
pubmed: 9008363
Front Microbiol. 2020 Aug 25;11:1963
pubmed: 32983007
J Phys Chem B. 2019 Jul 11;123(27):5814-5821
pubmed: 31251616
Nanomaterials (Basel). 2020 Feb 14;10(2):
pubmed: 32075033
Gene. 1995 Feb 27;154(1):87-92
pubmed: 7867956
Int J Mol Sci. 2020 Apr 10;21(7):
pubmed: 32290291
Antimicrob Agents Chemother. 1998 Aug;42(8):2055-9
pubmed: 9687406
Vet Microbiol. 2017 Jun;205:26-33
pubmed: 28622857
Nat Protoc. 2010 Apr;5(4):725-38
pubmed: 20360767
Anaerobe. 2018 Oct;53:108-115
pubmed: 29940245
J Biomol Struct Dyn. 2020 Jul;38(11):3396-3410
pubmed: 31422761
Annu Rev Biochem. 2009;78:119-46
pubmed: 19231985
Mikrobiyol Bul. 2012 Apr;46(2):276-82
pubmed: 22639316
Molecules. 2021 Oct 14;26(20):
pubmed: 34684780
Diagn Microbiol Infect Dis. 2014 Jun;79(2):141-3
pubmed: 24674093
BMC Infect Dis. 2020 Mar 18;20(1):228
pubmed: 32188401
Biophys J. 2017 Aug 8;113(3):550-557
pubmed: 28793210
Front Microbiol. 2020 Apr 03;11:566
pubmed: 32318043
Biochim Biophys Acta. 2016 Sep;1861(9 Pt A):1102-1110
pubmed: 27320015
Curr Microbiol. 2011 May;62(5):1363-7
pubmed: 21234755
Bioinformatics. 2014 Mar 15;30(6):884-6
pubmed: 24162465
Mini Rev Med Chem. 2020;20(17):1754-1766
pubmed: 32386492
Infect Drug Resist. 2018 Oct 12;11:1807-1817
pubmed: 30349337